分支链氨基酸与炎症性肠病之间的因果关系:双向和多变量门德尔随机化研究
Jiaying Zhou1, Fengting Zhu1, Leimin Sun2
1Department of Gastroenterology, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China.
British journal of hospital medicine (London, England : 2005)
|February 25, 2025
概括
增高的分支链氨基酸 (BCAA) 可能会增加克罗恩病的风险. 这项研究发现,较高的BCAA水平与克罗恩病之间存在因果关系,但不存在性结肠炎或整体炎症性肠病.
科学领域:
- 代谢学 代谢学 代谢学
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
背景情况:
- 分链氨基酸 (BCAA) 代谢与炎症性肠病 (IBD) 之间的联系需要进一步阐明.
- 调查BCAA水平和IBD亚型之间的潜在因果关系对于了解疾病的发病过程至关重要.
研究的目的:
- 使用双向,两样本的门德尔随机化 (MR) 方法,探索循环中的BCAA水平和IBD之间的潜在因果关系.
- 评估总BCAA,白素,素和异黄素与IBD风险的相关性.
主要方法:
- 利用全基因组关联研究 (GWAS) 的数据来确定BCAA水平,以及FinnGen研究数据来确定IBD及其亚型.
- 采用逆变量加权 (IVW) MR用于初级分析和多变量门德尔随机化 (MVMR) 来调整混因子.
主要成果:
- 在循环总BCAA水平 (白氨酸,氨酸,异氨酸) 和克罗恩氏病 (CD) 风险增加之间观察到积极的因果关系.
- 在BCAA水平和整体IBD或性结肠炎 (UC) 之间没有发现显著的因果关系.
- MVMR分析证实了高BCAA水平对CD风险的直接因果作用,独立于常见的风险因素.
结论:
- 循环中的BCAA水平升高与患克罗恩病的风险增加有关.
- 这些发现突出了BCAA作为克罗恩病管理中的潜在生物标志物或治疗点.
- 建议进行进一步的研究,以探索CD中BCAA失调的临床影响.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
294
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
294
01:17Irritable Bowel Syndrome I: Introduction
218
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
218
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
112
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
112
01:30Inflammatory Bowel Disease II: Crohn's Disease
157
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
157
01:17Chronic Bowel Disorders: Introduction
378
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
378
01:29Inflammatory Bowel Disease IV: Pharmacological Management
89
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
89